4//SEC Filing
Liu Joy 4
Accession 0000899243-22-018604
CIK 0000875320other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:18 PM ET
Size
12.3 KB
Accession
0000899243-22-018604
Insider Transaction Report
Form 4
Liu Joy
SVP, General Counsel
Transactions
- Sale
Common Stock
2022-05-16$250.77/sh−25$6,269→ 14,442 total - Sale
Common Stock
2022-05-16$254.36/sh−35$8,903→ 14,334 total - Sale
Common Stock
2022-05-16$251.57/sh−19$4,780→ 14,423 total - Sale
Common Stock
2022-05-16$252.49/sh−20$5,050→ 14,403 total - Sale
Common Stock
2022-05-16$253.87/sh−34$8,632→ 14,369 total
Footnotes (7)
- [F1]Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
- [F2]Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- [F3]Open market sales reported on this line occurred at a weighted average price of $250.77 (range $250.00 to $250.90).
- [F4]Open market sales reported on this line occurred at a weighted average price of $251.57 (range $251.05 to $251.81).
- [F5]Open market sales reported on this line occurred at a weighted average price of $252.49 (range $252.12 to $253.11).
- [F6]Open market sales reported on this line occurred at a weighted average price of $253.87 (range $253.14 to $254.13).
- [F7]Open market sales reported on this line occurred at a weighted average price of $254.36 (range $254.15 to $254.57).
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001847529
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:18 PM ET
- Size
- 12.3 KB